Caris Life Sciences, Inc.
CAI
Kedudukan dalam Saham
#2194
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing... Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Harga Saham
$32.28
Disegerakkan terakhir: 2026-10-21
Modal Pasaran
$9.12B
Perubahan (1 hari)
3.76%
Perubahan (1 tahun)
7.46%
Negara
US
Perdagangan Caris Life Sciences, Inc. (CAI)
Kategori
Healthcare
Sejarah pecahan saham untuk Caris Life Sciences, Inc. (CAI)
Saham Caris Life Sciences, Inc. (simbol: CAI) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 22, 2026.
Satu saham CAI yang dibeli sebelum Oct 22, 2026 kini bersamaan dengan 0 saham CAI.
Pecahan saham terkini berlaku pada Oct 22, 2026.
Satu saham CAI yang dibeli sebelum Oct 22, 2026 kini bersamaan dengan 0 saham CAI.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
